AstraZeneca Pharma announced its quarterly result yesterday. The company’s profit surged in the first quarter of the financial year 2016-17. The Indian arm of the multinational pharmaceutical company reported its net profit in the April-June period rising to Rs 10.6 crore from Rs 2.7 crore in the corresponding quarter last year.
AstraZeneca Pharma share price went up to Rs. 1,065.25 with the rise of over 5% on today morning trade.
The revenue for the quarter ended June improved by 15.1 percent to Rs 138.1 crore against Rs 120 crore on the year-on-year basis. Earnings before interest, taxes, depreciation and amortization went up to Rs 16 crore from Rs 5.3 crore in the corresponding quarter the previous year. The EBITDA margin expanded 750 basis points to 11.5 percent from 4 percent.
AstraZeneca Pharma share price opened at Rs. 1,090 against its previous day close of Rs. 1,013.85. The scrip touched the intraday high of Rs. 1,121.90 and the low of Rs. 1,050. AstraZeneca Pharma is in the top 500 performer list of Dynamic Levels for the quarter. The company has not reported any loss in last two-quarters and has nil debt-equity ratios. The current ratio of the company stands at 1.21 with 3.37% return on Equity.
AstraZeneca Pharma share price has been trading near its closest support level of Rs. 992.10. The nearest resistance for the stock stands at Rs. 1,081. For more details on the resistance and support level of the stock, visit AstraZeneca Pharma share price forecast page of the website. For other details, please visit AstraZeneca Pharma share price history page.
No comments:
Post a Comment